Rose became acquainted with Patient Worthy after her husband was diagnosed with Acute Myeloid Leukemia (AML) six years ago. During this period of partial remission, Rose researched investigational drugs to be prepared in the event of a relapse. Her husband died February 12, 2021 with a rare and unexplained occurrence of liver cancer possibly unrelated to AML.

    Tardive Dyskinesia: Phase 3 Study Results Indicate Improvement with Use of INGREZZA®
    source: pixabay.com

    Tardive Dyskinesia: Phase 3 Study Results Indicate Improvement with Use of INGREZZA®

    This week Neurocrine Biosciences announced the results of its KINECT®-4 Phase 3 study of INGREZZA® capsules. Results of the trial were published in the Journal of Clinical Psychopharmacology. A long-term…

    Continue Reading Tardive Dyskinesia: Phase 3 Study Results Indicate Improvement with Use of INGREZZA®
    Cartesian Therapeutics Earns Regenerative Medicine Advanced Therapy Designation for Myasthenia Gravis
    shutterstock.com

    Cartesian Therapeutics Earns Regenerative Medicine Advanced Therapy Designation for Myasthenia Gravis

    Cartesian Therapeutics, Inc., a biotechnology company, recently announced that the FDA has awarded the Regenerative Medicine Advanced Therapy (RMAT) designation to its lead product, Descartes-08, to treat myasthenia gravis (MG).…

    Continue Reading Cartesian Therapeutics Earns Regenerative Medicine Advanced Therapy Designation for Myasthenia Gravis
    Encouraging Results from a Phase 2 Study of IL-2 to Treat Alzheimer’s Patients
    kkolosov / Pixabay

    Encouraging Results from a Phase 2 Study of IL-2 to Treat Alzheimer’s Patients

    BioSpace recently published a press release discussing the interim results highlighting a Coya Therapeutics’ study. The study evaluates the safety, tolerability, and biological activity of LD IL-2 in 38 patients…

    Continue Reading Encouraging Results from a Phase 2 Study of IL-2 to Treat Alzheimer’s Patients
    Enrollment Completed in Clinical Trials for Primary Sjögren’s Syndrome and IgA Nephropathy
    source: shutterstock.com

    Enrollment Completed in Clinical Trials for Primary Sjögren’s Syndrome and IgA Nephropathy

    Jianmin Fang, M.D. the CEO of the biotechnology company RemeGen, recently announced in PRNewswire that the company is continuing its significant progress in its research of Telitacicept (RC18) to treat…

    Continue Reading Enrollment Completed in Clinical Trials for Primary Sjögren’s Syndrome and IgA Nephropathy
    Suicidal Bipolar Depression: Clinical Trial Results of NRX-101 Found Superior Safety and Similar Efficacy Compared to Lurasidone
    source: pixabay.com

    Suicidal Bipolar Depression: Clinical Trial Results of NRX-101 Found Superior Safety and Similar Efficacy Compared to Lurasidone

    People who have bipolar depression face a 50% lifetime risk of attempting suicide and a 20% risk of death from suicide. Over seven million people in the U.S. are struggling…

    Continue Reading Suicidal Bipolar Depression: Clinical Trial Results of NRX-101 Found Superior Safety and Similar Efficacy Compared to Lurasidone
    New FDA Regulation on Laboratory Developed Tests Draws Objections from Healthcare Groups
    source: shutterstock.com

    New FDA Regulation on Laboratory Developed Tests Draws Objections from Healthcare Groups

    As reported in Biopharma Dive, the FDA’s decision to strengthen its authority involving laboratory developed tests (LDTs) has drawn considerable objections from various healthcare groups. However, the Agency has held…

    Continue Reading New FDA Regulation on Laboratory Developed Tests Draws Objections from Healthcare Groups
    Health Canada Accepts Priority Review of New Drug Submission for Exa-cel for Sickle Cell Disease and Beta Thalassemia
    source: shutterstock.com

    Health Canada Accepts Priority Review of New Drug Submission for Exa-cel for Sickle Cell Disease and Beta Thalassemia

    Exa-cel Gene-Edited Therapy Vertex Pharmaceutical recently announced that Health Canada has accepted its New Drug Submission and granted Priority Review for Exa-cel, a gene-edited cell therapy, for the treatment of…

    Continue Reading Health Canada Accepts Priority Review of New Drug Submission for Exa-cel for Sickle Cell Disease and Beta Thalassemia
    Clinical Trial: Rinvoq 45 mg Brings ‘Rapid Resolution’ of Crohn’s Disease Symptoms
    source: shutterstock.com

    Clinical Trial: Rinvoq 45 mg Brings ‘Rapid Resolution’ of Crohn’s Disease Symptoms

    Patients with moderate to severe Crohn’s disease have found quick relief from abdominal pain and stool frequency during the first week of induction therapy according to data analysis published in…

    Continue Reading Clinical Trial: Rinvoq 45 mg Brings ‘Rapid Resolution’ of Crohn’s Disease Symptoms
    Investigational Treatment for ADPKD Earns FDA’s Orphan Drug Designation
    source: pixabay.com

    Investigational Treatment for ADPKD Earns FDA’s Orphan Drug Designation

    Approximately 540,000 individuals in the United States have been diagnosed with autosomal dominant polycystic kidney disease (ADPKD). The disease causes persistent and rapidly accumulating cysts to grow in the patient’s…

    Continue Reading Investigational Treatment for ADPKD Earns FDA’s Orphan Drug Designation
    Scientists have Discovered a Connection Between Metabolic Problems in the Brain and Neurological Disorders
    source: shutterstock.com

    Scientists have Discovered a Connection Between Metabolic Problems in the Brain and Neurological Disorders

      These efforts led to collaboration by the International Brain pH Project that involves 131 scientists in 105 labs from seven countries. The scientists have identified changes in lactate levels…

    Continue Reading Scientists have Discovered a Connection Between Metabolic Problems in the Brain and Neurological Disorders
    Researchers Discover ‘Super Minigene’ that Helps Find Potential Therapies for Spinal Muscular Atrophy
    source: shutterstock.com

    Researchers Discover ‘Super Minigene’ that Helps Find Potential Therapies for Spinal Muscular Atrophy

    For decades researchers have had to isolate segments of genes in order to study them. They called the isolated gene a “mini gene.” Ravindra Singh, a biomedical science professor at…

    Continue Reading Researchers Discover ‘Super Minigene’ that Helps Find Potential Therapies for Spinal Muscular Atrophy